Related Experiment Video
Updated: Oct 9, 2025
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
NOX4: a potential therapeutic target for pancreatic cancer and its mechanism
Yawei Bi1, Xiao Lei2, Ningli Chai3
1Department of Gastroenterology and Hepatology, The First Medical Center of PLA General Hospital, Beijing, 100853, China.
Abstract:
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) is one of the seven isoforms of NOX family, which is upregulated in pancreatic cancer cell, mouse model of pancreatic cancer and human pancreatic cancer tissue. NOX4 is a constitutively active enzyme that primarily produces hydrogen peroxide, which exhibits completely different properties from other subtypes of NOX family. More importantly, recent studies illuminate that NOX4 promotes pancreatic cancer occurrence and development in different ways. This review summarizes the potential roles and its mechanism of NOX4 in pancreatic cancer and explores NOX4 as the potential therapeutic target in pancreatic cancer.
Insights
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) is upregulated in pancreatic cancer, promoting its development. Targeting NOX4 offers a potential therapeutic strategy for pancreatic cancer treatment.
Area of Science:
- Biochemistry
- Oncology
- Molecular Biology
Background:
- Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) is an enzyme upregulated in pancreatic cancer.
- NOX4 produces hydrogen peroxide and differs from other NOX family members.
- Emerging evidence indicates NOX4's role in pancreatic cancer progression.
Purpose of the Study:
- To review the roles and mechanisms of NOX4 in pancreatic cancer.
- To explore NOX4 as a potential therapeutic target.
Main Methods:
- Literature review of studies on NOX4 in pancreatic cancer.
- Analysis of NOX4 expression and function in cancer models and tissues.
Main Results:
- NOX4 is upregulated across pancreatic cancer cell lines, mouse models, and human tissues.
- NOX4's constitutive activity and hydrogen peroxide production are key features.
- NOX4 actively promotes pancreatic cancer initiation and progression through various pathways.
Conclusions:
- NOX4 plays a significant role in pancreatic cancer.
- NOX4 represents a promising therapeutic target for pancreatic cancer intervention.
